RVMDRevolution Medicines, Inc.

$215.57

$34.7052 weeks$216.19

Price

$215.57+517%1Y

1M+14%1Y+517%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

10/10

Value97

Quality26

Momentum92

Growth-

Strongest Value, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. We possess sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Guided by our understanding of genetic drivers and adaptive resistance mechanisms in cancer, we deploy precision medicine approaches to inform innovative monotherapy and combination regimens.

In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$34.65B

1Y Return+517%

5Y Return+635%

For the full year FY2025, revenue was $0 and net income −$1.13B.